Here's what G.ai does
G.ai focuses on the tasks that take time but don't need your attention. It gathers information, filters noise, and highlights what's relevant so you can focus on the conversations and decisions that matter.
Startup snapshots
Ecosystem signals
Connecting people on ideas
Pre-meeting context
1. Smart day starter
Every morning, a snapshot of what to prioritize and what to ignore. G.ai analyzes your calendar, recent activity, and goals—then tells you: here's what moves the needle today, and here's what can wait. Work smarter, get more done, and finish your day with energy to spare.
Wednesday, Nov 19
LiveGood Morning,
Guy
Critical Opportunity
BioTech Alpha patent approved yesterday. Company actively seeking Lead Investor. Meeting at 10:00 AM.
Time Sensitive: 4h windowToday's Focus
Total Meetings
4
High Priority
1
Time Commitment
3.5h
AI Score Avg
76
AI Recommendations
Focus on BioTech Alpha
94% portfolio match
Delegate 2PM Retail call
Low priority · 43% match
Review metrics before 4PM
Prep for strategy session
2. Pre-meeting context
Ask G.ai about someone you're meeting and get the essentials in seconds, so that you could walk in from your back-to-back feeling prepared. Your AI agents compile everything—background, companies, track record, and hidden connections you won't find on LinkedIn.
Series A Investment Discussion
Virtual • 60 min
Strategic investment discussion for Series A funding round. BioTech Alpha seeks $15M to accelerate clinical trials and expand their R&D team. Founded by Michael Rodriguez, ex-Google AI engineer who previously built and successfully exited NeuralPath. Strong preliminary results with FDA fast-track designation.
Suggested Questions
Red Flags
Direct competitor GenEdit Labs launched similar product 2 weeks ago with FDA fast-track approval. This could affect market positioning and timeline to revenue.
Opportunity Evaluation
3. Startup snapshots
Quick assessments of any startup: strengths, gaps, and red flags. You'll have a meeting with every startup you're going to meet with. It would be the G.ai assessment. And you can always correct it, and then the AI will learn from it and improve over time.
BioTech Alpha
Series A · Biotech
AI gene editing with 40% higher precision. Patent-protected CRISPR platform for rare diseases. Strong technical moat with exceptional founding team.
- 3 breakthrough patents filed
- FDA trials Q2 2024
- Elite team: 3 Stanford PhDs
- $8B+ addressable market
BioTech Alpha
Series A · Biotech
AI gene editing with 40% higher precision. Patent-protected CRISPR platform for rare diseases. Strong technical moat with exceptional founding team.
- 3 breakthrough patents filed
- FDA trials Q2 2024
- Elite team: 3 Stanford PhDs
- $8B+ addressable market
4. Connecting people
If two people or companies should probably meet, GAI surfaces it.
Network Activity
Hey David, you have 12 important updates in your network this week. I think you should reach out to Sarah about her new role at Stripe—and NexusAI's funding round looks like a great opportunity for you to reconnect with the team.
Last Updates
Sarah Chen
New position: VP of Product at Stripe
Emma Wilson
Connected with David Park
David Park
Speaking at TechCrunch Disrupt
NexusAI
Raised $15M Series A
5. Ecosystem signals
Updates from LinkedIn, news, funding rounds, and posts: filtered so you only see what actually matters.
Personal Brand Monitor
Track your professional reputation in real-time
AI Platform Visibility
How You're Recognized
Recent Mentions
Great meeting with @GuyFranklin - invaluable BioTech insights.
Most productive networking session in NYC today.
Posted after your meeting
Thanks for the BioTech Alpha intro. Perfect fit.